Upanib 15mg tablet

Upanib 15mg tablet contains Upadacitinib, a targeted Janus Kinase (JAK) inhibitor. It is primarily prescribed to treat moderate to severe autoimmune and inflammatory conditions—such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis—by suppressing overactive immune responses and reducing joint inflammation.Key DetailsActive Ingredient: Upadacitinib (15 mg)Manufacturer: Ziska Pharmaceuticals LtdDrug Class: Immunosuppressant / JAK InhibitorIndicationsUpanib is prescribed to adults who have not responded adequately to or cannot tolerate traditional disease-modifying antirheumatic drugs (DMARDs) like methotrexate. Conditions treated include:Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis and Non-radiographic Axial SpondyloarthritisAtopic Dermatitis (Eczema) and Ulcerative Colitis